Veronique Gelebart

Veronique Gelebart is a seasoned clinical development professional with extensive experience in managing clinical operations and research teams across prominent organizations. Currently serving as the Clinical Development Program Lead at Eligo Bioscience since September 2024, Veronique previously held the position of Head Clinical Research Business Unit at Voisin Consulting Life Sciences from September 2022 to September 2024, where responsibilities included leading clinical trials and managing the business unit's P&L. Prior roles include Global Head of Clinical Development Operations and Global Head of Clinical Operations at AB Science (2019 - September 2022), as well as significant positions at Sanofi from 1991 to 2019, which encompassed oversight of oncology and rare disease global clinical trials and management of clinical data management teams. Veronique holds a Master's degree in Statistics from Université de Bretagne Occidentale.